Who is sponsoring NCT04901598?

NCT04901598 is sponsored by Cairo University.

What drugs are being tested in NCT04901598?

Interventions in NCT04901598: Running anaerobic sprint test and aerobic test.

What condition does NCT04901598 study?

NCT04901598 studies Premenstrual Syndrome.

Is NCT04901598 still recruiting?

NCT04901598 is currently completed. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT04901598

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome

Completed Last updated 20 July 2022

What this trial tests

trial testing Running anaerobic sprint test and aerobic test in Premenstrual Syndrome in 100 participants. Completed in 25 March 2022.

Timeline

20 October 2021

Primary endpoint
1 January 2022

25 March 2022

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	20 October 2021
Primary completion	1 January 2022
Estimated completion	25 March 2022
Sites	1 location across Egypt

Drugs / interventions tested

Running anaerobic sprint test and aerobic test

Conditions studied

Premenstrual Syndrome — all drugs for Premenstrual Syndrome →

Sponsor

Cairo University

Who can join

Adults 20 to 35, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the physical activity level, aerobic capacity and dietary habits among a cohort of females with premenstrual syndrome

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Premenstrual Syndrome

Currently open trials in the same condition.

NCT07202650 — THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME · NA · recruiting
NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
NCT06771583 — Identification and Validation of Epigenetic Biomarkers of PMDD · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04901598 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04901598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing